Dr. Gustafson earned his MD/PhD from the University of Texas Medical Branch where he specialized in cancer biochemistry and signaling. He completed his pediatrics residency at University of Texas Southwestern/Children’s Medical Center Dallas and his pediatric oncology fellowship training at the University of California San Francisco (UCSF). He is currently an Assistant Professor of Pediatrics at UCSF.
Dr. Gustafson’s laboratory focus is on the basic biology of MYC proteins in cancer and the preclinical development of novel therapeutics to target MYC and other oncogenic molecules in neuroblastoma and other diseases. In addition to his basic science work, he also runs correlary biology studies for several neuroblastoma clinical trials. His clinical focus is on early phase clinical trials for patients with relapsed or refractory neuroblastoma. Dr. Gustafson is the Principal Investigator on a number of grants funded by NIH, Department of Defense, several philanthropic organizations, and industry collaborators. He was recently selected as a William Guy Forbeck Scholar and is a member of the scientific review committee of the New Advances in Neuroblastoma Therapy (NANT) consortium.